Skip to main content
. Author manuscript; available in PMC: 2019 Feb 25.
Published in final edited form as: Eur J Med Chem. 2018 Jan 31;146:519–528. doi: 10.1016/j.ejmech.2018.01.053

Figure 4.

Figure 4

Effects of vemurafenib and compound 2d on downstream signaling of BRAFV600E in A375 cells. Vemurafenib (VEM) potently blocked phosphorylation of MEK while 2d had little effects at up to 100 μM. A375 cells were treated with vemurafenib or compound 2d at various concentrations before the cells were lysed, resolved by SDS-PAGE, transferred to PVDF membrane, and probed with antibodies for MEK and phospho-MEK (pMEK).